In the third panel of 6 adenocarcinoma-derived cell lines, a preferential knockdown of CTTN was observed across the board, and even in the case of alternate targets, the resulting knockdowns were much more conserved (Fig. 4C). This evidence concerns the gene CTTN and adenocarcinoma.